聚乙烯颗粒通过IL-33分泌诱导类似喘的Th2介导的肺损伤
Jong-Hwan Woo1, Mi-Kyung Song2, Seung Hoon Baek3
1Center for Respiratory Safety Research, Korea Institute of Toxicology, 30 Baehak1-gil, Jeongeup, Jeollabuk-do 56212, Republic of Korea; Biosafety Research Institute and Laboratory of Pathology, College of Veterinary Medicine, Jeonbuk National University, Iksan-si, Jeollabuk-do, Republic of Korea.
Environment international
|September 10, 2025
概括
吸入小聚乙烯 (PS) 微塑料会通过激活IL-33通路,在小鼠中引起喘类症状和肺炎. 通过阻断IL-33信号或使用德克萨米他来减少这些影响.
科学领域:
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
- 免疫学 免疫学 免疫学
背景情况:
- 由包装污染产生的聚钢 (PS) 微塑料对环境构成风险.
- 空气中的微塑料吸入对人类呼吸系统健康的关注日益增长.
研究的目的:
- 通过吸入来研究聚钢 (PS) 微塑料对肺部的有毒作用.
- 阐明由PS微塑料诱导的呼吸道炎症和免疫反应的机制.
主要方法:
- 仅通过鼻子吸入的小鼠暴露在PS微塑料 (50nm至1μm) 中.
- 评估喘类症状,呼吸道炎症和Th2免疫反应.
- 空间转录组分析以确定参与肺损伤的细胞通路.
- 在体外实验刺激上皮细胞和分析细胞反应.
- 用IL-33抑制剂和甲治疗,以评估治疗潜力.
主要成果:
- 吸入PS微塑料诱导了显著的喘症状,包括呼吸道炎症和高反应性.
- 较小的PS颗粒大小与更严重的肺炎反应相关.
- 皮质细胞被确定为IL-33信号通路和PS诱导的肺损伤中的Th2细胞激活的关键驱动因素.
- 暴露于PS增强了Th2免疫反应,由增加的细胞因子水平和mRNA表达体现出来.
- 抑制IL-33和甲治疗有效缓解了PS诱导的Th2介导的肺炎.
结论:
- 吸入聚乙烯微塑料对呼吸系统健康构成重大风险,诱导类似喘的疾病.
- 由上皮细胞驱动的IL-33信号通路在PS诱导的肺炎和Th2免疫反应中起着至关重要的作用.
- 准IL-33通路或使用抗炎药物,如德甲,对控制微塑性塑料诱导的呼吸系统损伤有希望.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:29Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K